Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 3/20 | 0.51 |
| ▸ | AGTR1 | P30556 | 4/20 | 0.50 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.47 |
| ▸ | LNPEP | Q9UIQ6 | 3/20 | 0.45 |
| ▸ | ANPEP | P15144 | 1/20 | 0.45 |
| ▸ | NTSR2 | O95665 | 5/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 5/20 | 0.44 |
| ▸ | CALCR | P30988 | 1/20 | 0.44 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.43 |
| ▸ | CMA1 | P23946 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19780925 | 0.92 | REN (0.56) | RENAGTR1AGTR2LNPEPANPEP | |
| SCHEMBL17274225 | 0.92 | REN (0.47) | RENAGTR1AGTR2LNPEPANPEP | |
| SCHEMBL17274191 | 0.91 | LNPEP (0.53) | AGTR1AGTR2LNPEPANPEPNTSR2 | |
| SCHEMBL18699907 | 0.84 | REN (0.52) | RENAGTR1AGTR2LNPEPANPEP | |
| SCHEMBL17287131 | 0.83 | AGTR1 (0.51) | AGTR1AGTR2NTSR2NTSR1CALCR | |
| SCHEMBL11204440 | 0.82 | LNPEP (0.60) | AGTR1AGTR2LNPEPANPEPNTSR2 | |
| SCHEMBL11204436 | 0.82 | LNPEP (0.60) | AGTR1AGTR2LNPEPANPEPNTSR2 | |
| SCHEMBL17274190 | 0.81 | C5AR1 (0.51) | AGTR1AGTR2NTSR1CALCRF2 | |
| SCHEMBL17287126 | 0.81 | C5AR1 (0.51) | AGTR1AGTR2NTSR1CALCRF2 | |
| SCHEMBL4757104 | 0.79 | AGTR1 (0.57) | RENAGTR1AGTR2LNPEPANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015179349-A2 | SYNTHESIS OF BETA-ARRESTIN EFFECTORS | TREVENA, INC. (US) | 2015-11-26 | — | — | WO | disclosed |